Literature DB >> 29194992

Monosaccharide Derivatives with Low-Nanomolar Lectin Affinity and High Selectivity Based on Combined Fluorine-Amide, Phenyl-Arginine, Sulfur-π, and Halogen Bond Interactions.

Fredrik R Zetterberg1, Kristoffer Peterson2, Richard E Johnsson3, Thomas Brimert3, Maria Håkansson4, Derek T Logan4,5, Hakon Leffler6, Ulf J Nilsson2.   

Abstract

The design of small and high-affinity lectin inhibitors remains a major challenge because the natural ligand binding sites of lectin are often shallow and have polar character. Herein we report that derivatizing galactose with un-natural structural elements that form multiple non-natural lectin-ligand interactions (orthogonal multipolar fluorine-amide, phenyl-arginine, sulfur-π, and halogen bond) can provide inhibitors with extraordinary affinity (low nanomolar) for the model lectin, galectin-3, which is more than five orders of magnitude higher than the parent galactose; moreover, is selective over other galectins.
© 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  fluorine multipolar interactions; galectin-3; halogen bonds; inhibitors; lectins; sulfur-π

Mesh:

Substances:

Year:  2018        PMID: 29194992     DOI: 10.1002/cmdc.201700744

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  16 in total

1.  Quinoline-Pyrazole Scaffold as a Novel Ligand of Galectin-3 and Suppressor of TREM2 Signaling.

Authors:  Moustafa Gabr; Ashfaq Ur Rehman; Hai-Feng Chen
Journal:  ACS Med Chem Lett       Date:  2020-08-11       Impact factor: 4.345

2.  Epimers Switch Galectin-9 Domain Selectivity: 3N-Aryl Galactosides Bind the C-Terminal and Gulosides Bind the N-Terminal.

Authors:  Mukul Mahanti; Kumar Bhaskar Pal; Anders P Sundin; Hakon Leffler; Ulf J Nilsson
Journal:  ACS Med Chem Lett       Date:  2019-12-04       Impact factor: 4.345

3.  Discovery and Optimization of the First Highly Effective and Orally Available Galectin-3 Inhibitors for Treatment of Fibrotic Disease.

Authors:  Fredrik R Zetterberg; Alison MacKinnon; Thomas Brimert; Lise Gravelle; Richard E Johnsson; Barbro Kahl-Knutson; Hakon Leffler; Ulf J Nilsson; Anders Pedersen; Kristoffer Peterson; James A Roper; Hans Schambye; Robert J Slack; Susan Tantawi
Journal:  J Med Chem       Date:  2022-09-26       Impact factor: 8.039

4.  Galectin-3 Inhibitors Suppress Anoikis Resistance and Invasive Capacity in Thyroid Cancer Cells.

Authors:  Jie-Jen Lee; Yi-Chiung Hsu; Ying-Syuan Li; Shih-Ping Cheng
Journal:  Int J Endocrinol       Date:  2021-05-07       Impact factor: 3.257

Review 5.  Galectins as Molecular Targets for Therapeutic Intervention.

Authors:  Ruud P M Dings; Michelle C Miller; Robert J Griffin; Kevin H Mayo
Journal:  Int J Mol Sci       Date:  2018-03-19       Impact factor: 5.923

6.  Aminopyrimidine-galactose hybrids are highly selective galectin-3 inhibitors.

Authors:  Alexander Dahlqvist; Fredrik R Zetterberg; Hakon Leffler; Ulf J Nilsson
Journal:  Medchemcomm       Date:  2019-05-13       Impact factor: 3.597

7.  Extracellular and intracellular small-molecule galectin-3 inhibitors.

Authors:  John Stegmayr; Fredrik Zetterberg; Michael C Carlsson; Xiaoli Huang; Gunjan Sharma; Barbro Kahl-Knutson; Hans Schambye; Ulf J Nilsson; Stina Oredsson; Hakon Leffler
Journal:  Sci Rep       Date:  2019-02-18       Impact factor: 4.379

8.  3-Substituted 1-Naphthamidomethyl-C-galactosyls Interact with Two Unique Sub-sites for High-Affinity and High-Selectivity Inhibition of Galectin-3.

Authors:  Alexander Dahlqvist; Santanu Mandal; Kristoffer Peterson; Maria Håkansson; Derek T Logan; Fredrik R Zetterberg; Hakon Leffler; Ulf J Nilsson
Journal:  Molecules       Date:  2019-12-12       Impact factor: 4.411

9.  Glycolipid-dependent and lectin-driven transcytosis in mouse enterocytes.

Authors:  Alena Ivashenka; Christian Wunder; Valerie Chambon; Roger Sandhoff; Richard Jennemann; Estelle Dransart; Katrina Podsypanina; Bérangère Lombard; Damarys Loew; Christophe Lamaze; Francoise Poirier; Hermann-Josef Gröne; Ludger Johannes; Massiullah Shafaq-Zadah
Journal:  Commun Biol       Date:  2021-02-09

Review 10.  Non-classical role of Galectin-3 in cancer progression: translocation to nucleus by carbohydrate-recognition independent manner.

Authors:  Seok-Jun Kim; Kyung-Hee Chun
Journal:  BMB Rep       Date:  2020-04       Impact factor: 4.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.